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Background: Fenestrated endovascular aneurysm repair uses the visceral aortic segment, in the setting of a suboptimal
proximal neck, for sealing and fixation. This technique requires the placement of visceral stents and might be hampered
by the deleterious effects of such interventions. This study was performed to define outcomes related to renal events.
Materials and Methods: Consecutive clinical records and radiographic studies of patients treated primarily with an
endovascular approach with a fenestrated endograft were reviewed. The population was divided into groups with and
without baseline renal dysfunction based on the National Kidney Foundation definition of chronic kidney disease.
Morphologic measurements and the detection of postoperative renal events such as renal artery stenosis or occlusion, need
for dialysis, deterioration of renal function by using estimated glomerular filtration rate (GFR), and secondary
interventions related to the renal arteries were assessed. Preoperative and postprocedural factors predictive for the
development of renal dysfunction were assessed by using a Fisher exact test, t test, and logistic regression.
Results: A total of 72 patients were treated between 2001 and 2004 with a mean age, aneurysm size, and follow-up of 75
years, 6.2 cm, and 6 months (range, 1 to 24 months), respectively. No ruptures and five deaths (two procedure-related)
were observed. There were 23 patients with baseline renal insufficiency and 49 patients without insufficiency. Twenty-
four patients had deterioration in GFR >30% during the follow-up period, and 17 patients experienced 19 renal-related
events (more common in patients with baseline insufficiency, 39% vs 16.3%; P  .04; relative risk, 2.4). Four patients
required dialysis (two permanent), and all had preoperative renal dysfunction (P  .002); similarly, death was also more
common in this group (17.4% vs 2%; P  .02; relative risk, 8.52). Renal events in most patients occurred within the first
postoperative month (59%). However, mean GFR stabilized after 6 months.
Conclusion: Aneurysm repair with fenestrated endovascular grafts is associated with a significant risk for adverse renal
events (16% in those without renal dysfunction, although none developed a creatinine >2 mg/dL, and 39% for patients
with preoperative renal dysfunction). These patients must be meticulously followed, particularly within the first month
after such a procedure. When renal artery restenosis is suspected or diagnosed, aggressive approach might be warranted
to limit the extent of late renal dysfunction. (J Vasc Surg 2005;41:181-90.)Endovascular repair of infrarenal abdominal aortic an-
eurysm has progressed rapidly following an improved un-
derstanding of the strengths and limitations of various
devices and treated patient populations.1-4 However, limi-
tations to the applicability of this technology center on the
suitability of proximal and distal sealing and fixation. Many
aspects of complex iliac artery morphologies can be man-
aged by using modified surgical techniques; however, the
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doi:10.1016/j.jvs.2004.11.025proximal neck remains challenging to address in a mini-
mally invasive manner. Although open surgical repair re-
mains the procedure of choice in patients without comor-
bid conditions,5-8 in the high risk patient, the absence of an
adequate proximal neck has been addressed by using a
fenestrated endovascular technique.9-12 Previous reports
with this technique,9,13 one pertaining to the first 22
patients in this study, have established its feasibility, reason-
able short-term safety, and high technical success rate.
However, a meticulous evaluation of renal function after
such repairs has not been conducted. It is the intention of
this article to further delineate the renal issues encountered
during and after fenestrated endovascular aneurysm repair
for juxtarenal aneurysm.
MATERIALS AND METHODS
Between August 2001 and February 2004, 72 patients
underwent primary endovascular repair for juxtarenal aneu-
rysms with a fenestrated device. Procedures were per-
formed under a Food and Drug Administration and insti-
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investigational device exemption trial. All patients were
considered high risk for open surgery, and their character-
istics have been previously described.9,13 Clinical records,
radiographic studies (kidneys, ureters, and bladder; duplex
scans; and computed tomography [CT] scans), and labora-
tory data of all patients undergoing primary endovascular
repair with fenestrated endografts were reviewed.
Follow-up studies were conducted at discharge, 1 month, 6
months, 12 months, and yearly thereafter. Patient’s assess-
ment included routine laboratory studies, calculation of
glomerular filtration rate (GFR), ankle/brachial index, vis-
ceral duplex scans, and CT scan of the abdomen and pelvis.
All CT scans were reconstructed by using thin-slice algo-
rithms (1-mm cuts) and were assessed by using multiplanar
and three-dimensional techniques. Duplex scans were per-
formed at an accredited vascular laboratory. Criteria used to
define the presence of renal artery stenosis included peak
systolic velocities 200 cm/s, end-diastolic velocity 100
cm/s, and renal to aortic ratio 3.5; kidney size and renal
resistive index were reported as well. Additional renal mor-
phologic reactions were assessed with CT scan (renal artery
patency, renal infarctions), whereas physiologic renal func-
tion was determined by using calculated GFR, the need for
dialysis, and any required secondary renal interventions.
Technical success was defined as the placement of a patent
endoprosthesis with all vessels initially intended to be in-
corporated into the desired fenestration remaining patent,
in addition to the absence of a type I or III endoleak.
Preoperative renal artery stenoses were treated at the time
of the aneurysm repair. Mechanical stent failure was diag-
nosed when objective evidence of metallic stent deforma-
tion was noted on follow-up studies (flat plate abdominal
radiographs, CT reconstructions, or follow-up angiogra-
phy).
The specific techniques used to implant these prosthe-
ses have been previously described.9,13 In brief, the device
is a modular system based on the Zenith aortic stent graft
(Cook Inc, Bloomington, Ind). The most proximal com-
ponent, containing the customized fenestrations as well as
the bare stent incorporating the barb mediated fixation
mechanism, is positioned, oriented, and deployed by un-
sheathing graft material. Access from the contralateral fem-
oral artery is required to cannulate fenestrations from
within the partially deployed prosthesis (Fig 1). Guiding
catheters are placed within the fenestrations (usually the
renal arteries), and the proximal fixation system is com-
pletely released. The renal arteries (and if necessary, any
additional visceral vessels) are then stented by using balloon
expandable systems, sized to the respective renal artery
ostial diameter. The visceral or renal stent is positioned to
protrude approximately 3 to 5 mm into the aortic lumen,
allowing a means to flare the aortic stent component, with
sequentially larger angioplasty balloons, such that it func-
tions as a rivet, apposing the aortic graft material against the
renal orifice. The remaining part of the procedure is carried
out in a manner similar to a conventional bifurcated Zenith
AAA deployment.14Calculated GFR was determined by using the abbrevi-
ated Modification of Diet in Renal Disease (MDRD) study
equation15-17: Estimated GRF (mL/min/1.73 m2) 
186(Scr)–1.154 (Age)–0.203 (0.742 if female) (1.210
if African American).
Although the GFR functions as a continuous variable,
an absolute cutoff of 60 mL/min/1.73 m2 has been rec-
ommended by the National Kidney Foundation to define
chronic kidney disease and underscore the need for further
clinical investigations regarding the etiology of renal dys-
function.15 Consequently, this value served as a means of
discriminating patients with pre-procedure renal dysfunc-
tion from those with normal preoperative renal function. A
relative decrease in GFR of greater than 30% was consid-
ered to represent a significant change after the procedure.
Patients with abnormal renal function during the follow-up
period were evaluated without contrast studies if severe
dysfunction was noted (baseline serum creatinine 2.5
mg/dL). However, if a contrast study was believed to be
critical for analysis or the patient had insulin-dependent
diabetes, studies were performed by using iso-osmolar con-
trast after premedication with renal protective agents (N-
acetyl-cysteine in serial doses 24 hours before evaluation
and for 12 hours after contrast administration) in addition
to 4 hours of intravenous hydration. Otherwise, a contrast
CT scan was done at each time point by using, in general,
100-150 mLs of contrast for the study.
Statistical analysis. Risk factors were analyzed with
respect to their association with mortality and renal events.
These included age, gender, coronary artery disease, smok-
ing, hyptertension, hyperlipidemia, diabetes, chronic ob-
structive pulmonary disease, aneurysm size, contrast vol-
ume, preoperative renal artery stenosis, and preoperative
renal function. For analysis purposes the cohort was divided
into two groups on the basis of the presence or absence of
preoperative renal dysfunction.
Relationships between categorical variables were as-
sessed with Fisher exact tests. Logistic regression was used
when the relationship was between a categorical response
and a continuous predictor. To compare means, t tests or
analysis of variance were used. Multivariate logistic regres-
sion was used to analyze adjusted effects. Kaplan-Meier and
log-rank tests were used to analyze survival responses. All
analyses were done by using JMP 5.1 (2003; SAS Institute,
Cary, NC).
RESULTS
A total of 72 patients were enrolled during the study
period. Baseline renal dysfunction (GFR  60 mL/min/
1.73 m2) was noted in 32% of the patients (23 of 72).
Demographic information is presented in Table I. The
overall mean creatinine level and calculated GFR at enroll-
ment were 1.1  0.41 mg/dL and 77.5  31 mL/min/
1.73 m2, respectively. There were no patients on dialysis
before the procedure. Mean aneurysm size was 6.2 cm. The
average contrast volume used during the procedure was
175 mL (standard deviation, 47.5). There were 28 patients
with at least one preoperative renal artery stenosis of50%.
tery d
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no acute or chronic ruptures or conversions. Successful
access into all but 1 of the 142 renal fenestrations was
achieved at the time of initial deployment. The single case
of renal access failure resulted in renal artery thrombosis
before the predischarge CT scan. All cause mortality
through the follow-up period was 6.9% (5 of 72), of which
two deaths were related to the procedure.
Renal-related outcome. The two groups delineated
by the presence or absence of baseline renal dysfunction
(GFR 60 and GFR 60) were similar in terms of age,
gender, non-renal comorbidities, and follow-up compli-
ance (Table I). During the course of follow-up, 17 patients
were noted to have renal-related events (10 renal artery
stenoses, 5 renal artery occlusions, and 4 patients required
hemodialysis, 2 of which occurred in the setting of the
aforementioned renal occlusions) (Fig 2). Baseline renal
dysfunction was a strong predictor for increased mortality
(P  .02; relative risk, 8.52), and the Kaplan-Meier mor-
tality rates, segregated by renal risk, are depicted in Fig 3.
The two procedure-related deaths included a single patient
Fig 1. Bilateral renal access is established before comple
image depicts guiding catheters into each of the single re
the stent graft can be completely expanded before the plac
the guiding catheters and deployed to the ostial renal ardying of aspiration attributed to a recurrent ileus, whichdeveloped after a planned hypogastric artery bypass
through a retroperitoneal incision before insertion of the
endograft. The second patient had distal embolization af-
fecting the renal and visceral vessels. He required postpro-
cedure hemodialysis and ultimately died, after a prolonged
hospital course, as a result of multisystem organ failure. The
overall incidence of adverse events decreased over time
(first year, 40%; second, 26%; and third, 10%). There were
no other aneurysm-related deaths.
Renal artery stenoses. A total of 10 renal artery ste-
noses (60 %) were detected throughout the study. One
resulted from fabric impingement in the setting of a prox-
imal scallop, where a renal stent was placed 5 days after the
initial procedure. A second patient had stent deformity
presumably resulting from caudal aortic component move-
ment (Fig 4) and was also treated with another renal stent.
The remaining eight cases occurred in the absence of any
detectable mechanical abnormality, and thus the restenosis
has been attributed to neointimal hyperplasia. Of these, five
have been observed and three treated with repeat angio-
plasty and stenting. Three of the 10 patients with renal
aft deployment and removal of the delivery system. This
teries. The guiding catheters are used as rails over which
t of renal stents. The stents are then introduced through
iameter. The aortic portion is then flared as desired.te gr
nal ar
emenartery stenoses had a decrease in the GFR 30%, one of
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gressed to require hemodialysis.
Renal artery occlusions. Five renal artery occlusions
were detected. Two renal artery occlusions were observed
in the absence of postprocedure renal stenosis after pro-
longed periods of hypotension. In both instances, the event
17 Patie
e
10 Renal Stenosis 5 Renal Occlusion
2
2 
1 r
1
Un
5 treated 
5 observed  
(treatment pending)
2/5 with decreasing 
 GFR 
1/5 with decreasing 
GFR
Fig 2. Summary of renal-related events and outcome. T
Table I. Demographics comparing groups of GFR  60
mL/min/1.73 m2 and GFR 60 mL/min/1.73 m2
GFR  60 mL/
min/1.73 m2
GFR  60 mL/
min/1.73 m2
P
value
Total patients 23 (32%) 49 (68%) N/A
Age (y) 76.1* 75.2* .61
Smoking 14 (61%) 36 (73%) .28
Gender/male 16 (70%) 43 (88%) .07
CAD 20 (87%) 39 (80%) .44
Hypertension 20 (87%) 33 (67%) .07
Hyperlipidemia 11 (48%) 16 (33%) .22
Diabetes mellitus 3 (13%) 9 (18%) .56
COPD 10 (43%) 20 (41%) .83
Mean follow-up
(range, 1–24 mo)
5.8 mo* 4.8 mo* .5
There were no statistical differences between groups. 70% (50/72) had
three risk factors or more, and 46% had four risk factors or more. None of the
risk factors was a significant independent predictor for the occurrence of
renal events.
N/A, Not applicable; CAD, coronary artery disease (primarily including
patients with a positive stress test result without an option for percutaneous
treatment or at a high risk for surgery, in addition to those patients with
severe congestive heart failure, and symptomatic coronary disease); COPD,
chronic obstructive pulmonary disease (included in general patients already
on treatment for this condition, patients with forced expiratory volume in 1
second 1 L, and patients on home oxygen).
*Mean.also present in the hemodialysis group. All patients requiringresulting in the hypotension was remote from, and unre-
lated to, the aneurysm repair. Two renal artery occlusions
were noted in the absence of mechanical deformation or
hypotension and thus hypothetically related to intimal hy-
perplasia. An additional occlusion occurred in a patient in
whom the fenestration was aligned with the renal ostium,
but technical difficulties precluded stent placement
through the fenestration. The renal artery was patent at
the completion angiogram, but it occluded before the
predischarge CT scan. All patients with postprocedure
renal artery occlusions exhibited a decrease in their renal
function 30% as measured by the calculated GFR, two
of whom, both with baseline renal insufficiency, required
hemodialysis.
Association of renal events to baseline renal
dysfunction. Baseline renal insufficiency was present in
nine of the 17 patients who experienced renal events,
making baseline renal dysfunction an important predictor
of adverse renal events (P  .04; odds ratio, 3.3). Further-
more, all four patients who required hemodialysis (two of
whom were treated with dialysis transiently) had significant
baseline renal dysfunction as well. Although observed de-
terioration in renal function at any time of more than 30%
was more common in patients with baseline renal dysfunc-
tion, this difference did not reach statistical significance
(43% vs 29%, P .21). However, this decrease in GFR was
not sustained beyond 6 months in the majority of these
patients. The observed mean GFR (Fig 5) had an acute
drop in both groups immediately after procedure; however,
by the 6-, 12-, and 24-month follow-up visits, the calcu-
lated GFR returned to within 30% of the baseline in the vast
majority of patients. Furthermore, despite the acute GFR
ith renal 
s
4 Hemodialysis 
2 Permanent 
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2 deaths 
1 related, 1 unrelated 
e 
is 
ed 
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line renal function deteriorated to have a serum creatinine
level greater than 2.0 mg/dL.
Fenestration and double renal arteries. Of the 142
renal fenestrations (19 of which were scallops), five patients
had two renal arteries arising from a single fenestration.
Each of these patients was treated by using a kissing stent
technique within the single fenestration. During the
follow-up period, one of these patients experienced occlu-
sion of both of the renal stents within the single fenestra-
tion. The remaining four patients have exhibited patent
double renal stents without evidence of restenosis.
Imaging at follow-up. Although renal patency was
assessed with duplex scanning and CT data, the detection
of a renal stenosis required an adequate duplex ultrasound
scan. A total of 222 renal arteries were interrogated with
duplex ultrasound scanning during the follow-up period, of
which 97 (44%) rendered conclusive data regarding the
presence or absence of a renal stenosis. Nonetheless, more
than 70% of the patients had at least one interpretable renal
duplex scan during the follow-up period. Suboptimal stud-
ies (which were attributed to bowel gas, obesity, or inability
to visualize the renal artery) and incomplete studies (in
which only a portion of the renal artery was visualized) were
considered inconclusive. However, the specificity of duplex
diagnosed renal stenoses was 100%, as evidenced by confir-
mational angiography in which all stenoses were treated.
This occurred in seven patients, none of whom had renal
stenosis suspected from CT reconstructions.
DISCUSSION
Renal dysfunction is prevalent after abdominal aortic
aneurysm repair. Furthermore, postprocedure renal dys-
Fig 3. Kaplan-Meier curves for survival in months. The
The bottom curve is for patients with renal dysfunction at
figure. Survival in the two groups is statistically differentfunction is a strong predictor of poor long-term survival.Open repair of infrarenal aneurysms has been associated
with a 51% ten-year survival in the absence of observed
renal dysfunction; this decreases to only12% survival at 10
years in the setting of renal dysfunction (P  .001).18
Fortunately, the incidence of renal failure after open or
endovascular repair is low (frequency varies with the actual
definition of events), ranging between 2.5% and 8%. How-
ever, the sensitivity of such studies is low because most rely
solely on an increasing creatinine level, a relatively insensi-
tive marker for renal dysfunction.4,18,19 The indication for
a fenestrated device, in contrast to an endograft that seals in
the infrarenal aorta, would be analogous to differentiating
open repairs that require suprarenal or supraceliac clamping
with anastomoses frequently incorporating the lowest renal
artery to traditional infrarenal clamping in the setting of an
adequate neck. The open surgical treatment of juxtarenal
aneurysms has been associated with a higher renal risk, with
reports of renal dysfunction ranging from 12% to 28.3%
where approximately 5.8% of the patients required dialy-
sis.5,7 Even worse outcomes are associated with thoracoab-
dominal repairs in which an 18% incidence of severe renal
dysfunction was noted with 9% requiring dialysis.20 Re-
gardless of the aneurysm location, the presence of preoper-
ative renal insufficiency remains a strong predictor of pro-
gressive renal dysfunction, whereas other factors, such as
clamp position, diabetes, or old age are variably associated
with worse renal outcomes.5-7
Prior articles with fenestrated grafts have reported a low
incidence of renal problems. Anderson et al10 treated 13
patients with one renal artery loss (7%); our first report of
22 patients noted a 14% incidence of rising creatinine
level,9 whereas a later update had 32 patients13 of whom
19% had increasing creatinine levels. The method of renal
rve is for patients without renal dysfunction at baseline.
ine. The total patients at risk is given at the bottom of the
.02).top cu
baselassessment in this article is more detailed than the afore-
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patent but noted to be occluded during the follow-up period. Angiography confirmed the occlusion and noted only
mild stent deformation (black arrow) on multiple oblique projections, which did not differ from its immediate
post-implantation appearance. The boundary of the fenestration is demonstrated with white arrows. The position of the
renal stent in the lower segment of the fenestration implies that the device has not moved at all in a caudal direction. In
contrast, in B is shown a renal stent that has been crushed by the device, either from torque or caudal migration. Note
the stent deformation that has occurred and the position of the stent with respect to the fenestration (white arrows). Its
location in the uppermost portion of the fenestrated orifice implies some caudal device movement (3 mm by CT scan).
The resultant renal artery stenosis was detected by duplex ultrasonography and treated with a supplemental stent that
is relatively stiffer in nature (C).
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Volume 41, Number 2 Haddad et al 187Fig 5. A, The initial decrease in GFR, followed by stabilization in renal function within 6 months of the procedure,
is noted in both groups of patients. This leads one to assume that there is a lack of ongoing renal insult, because there
is no continued deterioration of GFR over time. When analyzed in a more specific per patient manner (B), expressed
as a relative percent change in GFR over time, there is an improvement in GFR in subset of patients with renal
dysfunction. This might indicate an aspect of renal recovery in these patients. C, Shown is delta % GFR over time
segregated by preoperative renal artery stenosis. There is no significant difference in the change in GFR over time
between the two groups.
JOURNAL OF VASCULAR SURGERY
February 2005188 Haddad et almentioned analyses, and the follow-up duration is longer,
which might account for the relatively higher incidence of
observed renal dysfunction.
Unfortunately, there is no universally accepted defini-
tion for kidney disease. This study used the guidelines
published by the National Kidney Foundation,15,17 which
defined a measured or calculated GFR60 mL/min/1.73
m2 as representative of chronic kidney disease. Measured
GFR through 24-hour urine collection was thought to be
impractical in this patient population; thus, GFR estimates
(with the abbreviated MDRD equation15-17) were used in
an effort to assess renal function as accurately as possible in
a longitudinal fashion. In this manner, our patients were
classified into a group without baseline renal dysfunction
(baseline GFR 60 mL/min/1.73 m2) and a group with
preoperative renal dysfunction (GFR 60 mL/min/1.73
m2), and relative changes were documented.
Overall, the detrimental effect of this method of juxta-
renal aneurysm repair on renal function does not appear to
differ from alternative treatments. There is a low incidence
of renal occlusion (5 of 142 treated arteries) and similarly a
low incidence of postprocedural renal artery stenosis (10 of
142 treated, although not all were adequately imaged with
duplex ultrasound scanning). All of the patients who re-
quired hemodialysis (4 of 72) had significant pre-existing
renal insufficiency. Functional renal assessment provides
some reassurance that a sustained decrease in the GFR
30% is uncommon, and baseline values are largely recov-
ered within 6 months of the procedure. However, there is
an initial detrimental effect on renal function that is associ-
ated with the implantation procedure. More than half
(58%) of all renal events occurred within the first month of
follow-up, which coincides with the periprocedural de-
crease in the mean GFR depicted in Fig 5. Ultimately,
worsening renal function after fenestrated endovascular
grafting was noted to be more prevalent in the setting of
pre-existing renal dysfunction and associated with a higher
risk of death.
Periprocedural renal dysfunction. There was a tran-
sient decrease in calculated GFR in 29% of the patients
without baseline renal insufficiency (although none in-
creased their serum creatinine level to greater than 2 mg/
dL) and 43% of patients with pre-existing renal dysfunc-
tion. The etiology of this problem is likely multifactorial. In
addition to the renal risk from contrast use, a significant
amount of device manipulation occurs within the proximal
neck as the endoprosthesis is accurately oriented, posing an
increased risk of atheroembolism. It is interesting to note
that the highest incidence of events occurred within the
first year of our experience with the device, underscoring
the importance of the learning curve. Thus, it appears that
undesirable renal outcomes are temporally related to the
procedure (which is not different than adverse renal effects
observed with non-fenestrated devices19) and also associ-
ated with a learning curve. The potential to limit such
dysfunction might require extremely accurate deployment
to minimize the amount of device movement sheath retrac-tion, the use of alternative contrast agents, and possibly the
implementation of renal embolic protection devices.
Device design and renal events. Acute renal events
can be categorized as those affecting the integrity of the
major renal vascular supply or renal parenchymal events.
Acute renal artery loss relates most closely to device design,
specifically the orientation and construct of the fenestra-
tions, as well as technical ability during the implantation
procedure. Angulated necks and small renal ostia (ie, those
with pre-existing stenoses) will make renal access more
challenging. We have learned several critical lessons from
our experiences. Device design is clearly more complex
than for conventional infrarenal prostheses. Although it
would appear that three-dimensional centerline of flow
measurements would be ideal for fenestrated designs, par-
ticularly in the setting of aortic angulation, the ability to
properly delineate the relative positions of the visceral
arteries is not straightforward. Angulation of the aortic
neck has the potential to induce disparity between the renal
ostia. This is readily evident when evaluating an angulated
aorta with an anteroposterior aortogram. When algorithms
are used to reconstruct images perpendicular to a centerline
of flow, the renal disparity frequently disappears. However,
when a prosthesis is positioned within the visceral aortic
segment, it frequently will not deploy along the calculated
centerline of flow and instead deploys perpendicular to the
axis of the delivery system. Thus, if the preoperative design
is based on centerline calculations and the device does not
deploy along the centerline, visceral vessel cannulation and
protection will be compromised. Thus, device design is best
accomplished in the setting of tortuous anatomy by using a
combination of techniques including centerline measure-
ments, angiography, or maximal intensity projections. Ul-
timately, one must predict how the device will situate
within the aorta in the setting of severe tortuosity before
the placement of fenestrations. Even if the fenestrations are
perfectly aligned with the renal ostia, they still likely require
stents within them. The only patient in whom a small
fenestration was not stented suffered from a renal artery
occlusion, and thus, it cannot be assumed that renal pa-
tency will be maintained in the absence of a stent.
Renal artery stenting. The intention of a renal stent
placed within an aortic fenestration is to maintain the
patency of the renal artery, thus protecting it from impinge-
ment of stent graft fabric. Unfortunately, an ideal renal
stent does not exist for conventional occlusive lesions,
much less for use with a fenestrated endograft. Optimally, a
stent designed for use with a fenestrated endograft would
be composed of a renal segment capable of treating an ostial
stenosis (if present), whereas the aortic segment should be
flareable, allowing the renal stent to function as a rivet,
pulling the endograft fabric against the perirenal aorta to
accentuate a seal and also provide a wide ostium to allow for
ready access if secondary renal interventions should be
necessary. The presence of a renal stent unlikely provides
protection from longitudinal migration; instead the stent
will more commonly be subject to the position of the aortic
prosthesis. Hypothetically, stent deformation can result
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aortic component. The single case in which stent deformity
was noted was likely associated with a slight downward
migration (approximately 3 mm) of the aortic device. Al-
though the renal stent was initially placed into the mid-
portion of the fenestration, the stent was located at the
uppermost segment of the fenestration at the time of noted
deformity, implying that the body of the aortic device had
moved downward slightly. For this reason, we also favor the
placement of renal stents in the lower section of the fenes-
tration, so that if a small amount of caudal movement
occurs (as might happen as the barbs engage in the aortic
wall), the stent is not subject to compression from the top
of the fenestration border. This type of repair relies heavily
on durable fixation systems and long-term protection from
migration. Rotational forces (torque), as opposed to longi-
tudinal forces, are important in the setting of a fenestrated
graft, but not for infrarenal prostheses. However, it is likely
that such torque would be markedly less than any down-
ward force associated with a migrating stent graft. Having
said this, when torque is suspected (such as cases in which
the fenestrations are not quite properly aligned with the
visceral ostia), a stiffer rather than flexible stent should be
used. Inherent in the stent construct, the ability to flare a
longitudinally rigid stent is diminished, and thus the added
benefit of an aortic flare is lost in these circumstances. The
use of similar stent designs in each of the fenestrations for a
given device should be encouraged. This is advocated to
diminish the likelihood that the stiffer stent will function as
a fulcrum, if rotational force should exist, and potentially
sacrifice the less stiff stent. Many companies are developing
better renal stents; some are specifically designed to incor-
porate some of the attributes required for fenestrated en-
dografting.
Study limitations. This series has several shortcom-
ings. The duration of the follow-up is relatively short and
represents only early intermediate-term results. Thus, the
ability to predict the long-term incidence of renal effects is
absent. Furthermore, the successful visualization of all renal
arteries with duplex ultrasound scanning was limited. Less
than half of the studies rendered conclusive results (how-
ever, more than 70% of the patients had interpretable
results during at least one follow-up visit). The reasons for
this relate to a relatively high incidence of obesity in this
patient population but also to the technical challenges
associated with post-stent renal artery interrogation. We
have attempted to improve our success by identifying select
individuals who will be responsible for the bulk of the
studies, thus concentrating the experience among a few
people. Finally, the data are representative of a single center
in which all of the procedures were either performed or
supervised by one physician. The ability to disseminate this
technology to other physicians is currently being studied in
a multicenter format.
Renal-related complications after fenestrated endovas-
cular grafting compare favorably with open juxtarenal an-
eurysm repair,5,7 despite the high risk patient population
treated. The prevalence of baseline renal dysfunction as aharbinger of an increased risk for bothmortality and further
renal deterioration also corroborates with findings after
open surgical repair. The high technical success rate and
comparably acceptable risk of death or renal dysfunction
support the use of fenestrated endovascular grafts as an
alternative for patients at high risk for an open surgical
procedure. The risk of severe renal events in patients with-
out baseline renal dysfunction was quite low (no patients
required dialysis in this group) and defines the renal safety
of this device in such a patient population. The prevalence
of the observed renal events during the immediate periop-
erative period and during the early learning curve of this
procedure underscores the importance of meticulous de-
vice planning, careful implantation techniques, and de-
tailed renal assessments at these times. When suspected,
renal stenoses should be evaluated in an effort to differen-
tiate the etiology of the problem and potential treatment
options. Ultimately, refinements in both the endovascular
graft and mating renal stent technology will help to ame-
liorate this problem as we progress beyond early generation
devices.
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